Hesham Nasser

9PUBLICATIONS
55CO-AUTHORS
Medical devicesOrganic chemical synthesisMedical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)Biological adaptation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 29, 2026
Author Correction: Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant.

|Dec 14, 2025
A non-spike nucleocapsid R204P mutation in SARS-CoV-2 Omicron XEC enhances inflammation and pathogenicity.

Shuhei Tsujino, Masumi Tsuda, Sayaka Deguchi

|Jul 30, 2025
Possible Crosstalk and Alterations in Gut Bacteriome and Virome in HIV-1 Infection and the Associated Comorbidities Related to Metabolic Disorder.

Komal Shrivastav, Hesham Nasser, Terumasa Ikeda

|Feb 26, 2025
APOBEC3-Related Editing and Non-Editing Determinants of HIV-1 and HTLV-1 Restriction.

Sharee Leong, Hesham Nasser, Terumasa Ikeda

|Feb 08, 2024
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant.

Tomokazu Tamura, Takashi Irie, Sayaka Deguchi

|May 16, 2023
Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants.

Tomokazu Tamura, Jumpei Ito, Keiya Uriu

Pageof 2

Frequent Collaborators

9 joint publications

Terumasa Ikeda

7 joint publications

Jumpei Ito

7 joint publications

Shinya Tanaka

7 joint publications

Masumi Tsuda